{"url_path":"/sec/anro/8-k/2026-07-13/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 ****Results of Operations and Financial Condition.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-13","source_url":"https://www.sec.gov/Archives/edgar/data/1999480/0001104659-26-082875-index.html","accession_number":"0001104659-26-082875","cik":"0001999480","ticker":"ANRO","issuer_name":"Alto Neuroscience, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1999480/0001104659-26-082875-index.html","primary_entity_key":"0001999480","primary_entity_name":"Alto Neuroscience, Inc."},"word_count":106,"has_tables":true,"body_markdown":"**Item 2.02.****Results of Operations and Financial Condition.**\n\n** **\n\nThe information disclosed under the heading “Cash,\nCash Equivalents and Restricted Cash as of June 30, 2026” under Item 8.01 of this Current Report on Form 8-K is incorporated\nherein by reference and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as\namended (the “**Exchange Act**”), or otherwise subject to the liabilities of that section, nor shall it be deemed\nincorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set\nforth by specific reference in such a filing."}